1. Home
  2. CDIO vs POM Comparison

CDIO vs POM Comparison

Compare CDIO & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

N/A

Current Price

$1.65

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Logo POMDOCTOR LIMITED American Depositary Shares

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$1.61

Market Cap

5.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
CDIO
POM
Founded
2017
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
5.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CDIO
POM
Price
$1.65
$1.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.9K
★ 4.1M
Earning Date
12-01-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $14,825.00
N/A
Revenue This Year
$168,534.06
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.97
$0.06
52 Week High
$7.91
$5.69

Technical Indicators

Market Signals
Indicator
CDIO
POM
Relative Strength Index (RSI) 41.69 49.06
Support Level $1.53 $0.14
Resistance Level $2.20 $1.78
Average True Range (ATR) 0.13 0.24
MACD -0.00 -0.04
Stochastic Oscillator 12.87 10.34

Price Performance

Historical Comparison
CDIO
POM

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: